Association between tumor mutational burden (TMB) assessed by whole-exome sequencing (WES) and outcomes of pembrolizumab (pembro) monotherapy

被引：5
|
作者：
Cristescu, Razvan [1 ]
Aurora-Garg, Deepti [1 ]
Albright, Andrew [1 ]
Xu, Lei [1 ]
Liu, Xiao Qiao [2 ]
Loboda, Andrey [1 ]
Lang, Lixin [1 ]
Jin, Fan [1 ]
Snyder, Alexandra [1 ]
Lunceford, Jared [1 ]
机构：
[1] Merck & Co Inc, Kenilworth, NJ USA
[2] MSD China, Beijing, Peoples R China
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-LB-261
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-261
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Association of tumor mutational burden (TMB) and clinical outcomes with tislelizumab versus chemotherapy in esophageal cell carcinoma (ESCC) from RATIONALE-302
    Shen, Lin
    Shu, Yongqian
    Zhao, Kuaile
    Satoh, Taroh
    Chen, Zhendong
    Van Cutsem, Eric
    Yu, Guohua
    Wu, Jun
    Hsu, Chih-Hung
    Kim, Sung Bae
    Du, Wenting
    Shi, Yang
    Huang, Ruiqi
    Li, Qiao
    Shi, Jingwen
    Zhang, Yun
    Ken, Kato
    CANCER RESEARCH, 2023, 83 (08)
  • [42] Clonal mutation burden and evolutionary dynamics analysis in metastatic gastro-esophageal adenocarcinoma (GEA) by error corrected whole-exome circulating tumor DNA sequencing
    McCafferty, Neil
    Fong, Caroline
    Barber, Louise J.
    Woolston, Andrew
    Kleftogiannis, Dimitrios
    Rana, Taqia
    Cromarty, Susan
    Kidd, Shannon
    Begum, Ruwaida
    Chau, Ian
    Starling, Naureen
    Cunningham, David
    Gerlinger, Marco
    CANCER RESEARCH, 2023, 83 (07)
  • [43] Tumor mutational burden (TMB), T cell-inflamed gene expression profile (GEP) and PD-L1 are independently associated with response to pembrolizumab (Pembro) in patients with advanced melanoma in the KEYNOTE (KN)-006 study
    Ribas, Antoni
    Robert, Caroline
    Schachter, Jacob
    Long, Georgina V.
    Arance, Ana
    Carlino, Matteo S.
    Larkin, James
    Webber, Andrea L.
    Lunceford, Jared
    Zhao, Qing
    Cristescu, Razvan
    Nebozhyn, Michael
    Zhang, Chunsheng
    Blumenschein, Wendy
    Krepler, Clemens
    Ibrahim, Nageatte
    Daud, Adil
    Grob, Jean-Jacques
    CANCER RESEARCH, 2019, 79 (13)
  • [44] GENOME-WIDE ASSOCIATION OF COPY NUMBER VARIANTS FROM WHOLE-EXOME SEQUENCING DATA REVEALS AN ASSOCIATION BETWEEN EXTREMES IN WORKING MEMORY PERFORMANCE AND RARE CNVS
    Heck, Angela
    Milnik, Annette
    Vukojevic, Vanja
    Petrovska, Jana
    Freytag, Virginie
    de Quervain, Dominique J. -F.
    Papassotiropoulos, Andreas
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1218 - 1218
  • [45] In Reply: DDR Pathway Alteration, Tumor Mutation Burden and Cisplatin Sensitivity in Small Cell Lung Cancer: Difference Detected by Whole-Exome and Targeted-Gene Sequencing
    Park, Sehhoon
    Lee, Se-Hoon
    Park, Keunchil
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (12) : E279 - E280
  • [46] Association between KCNQ2, TCF4 and RGS18 polymorphisms and silent brain infarction based on whole-exome sequencing
    Kim, Jung Oh
    Lee, Kee Ook
    Kim, Hyun Woo
    Park, Han Sung
    Kim, Jinkwon
    Sung, Jung Hoon
    Oh, Doyeun
    Kim, Ok Joon
    Kim, Nam Keun
    MOLECULAR MEDICINE REPORTS, 2020, 21 (04) : 1973 - 1983
  • [47] Association Between Preanalytical Factors and Tumor Mutational Burden Estimated by Next-Generation Sequencing-Based Multiplex Gene Panel Assay
    Quy, Pham Nguyen
    Kanai, Masashi
    Fukuyama, Keita
    Kou, Tadayuki
    Kondo, Tomohiro
    Yamamoto, Yoshihiro
    Matsubara, Junichi
    Hiroshima, Akinori
    Mochizuki, Hiroaki
    Sakuma, Tomohiro
    Kamada, Mayumi
    Nakatsui, Masahiko
    Eso, Yuji
    Seno, Hiroshi
    Masui, Toshihiko
    Takaori, Kyoichi
    Minamiguchi, Sachiko
    Matsumoto, Shigemi
    Muto, Manabu
    ONCOLOGIST, 2019, 24 (12) : E1401 - E1408
  • [48] Association between tumor mutational burden (TMB) and immune-related adverse events (irAEs) in patients (pts) with metastatic urothelial carcinoma (mUC) during checkpoint immunotherapy.
    Akl, Elie W.
    Nuzzo, Pier Vitale
    Adib, Elio
    Nassar, Amin
    Abou Alaiwi, Sarah
    Ravi, Praful
    Mantia, Charlene
    Sonpavde, Guru
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [49] Association between sample characteristics and tumor mutational burden estimated by next-generation sequencing-based multiplex gene panel assay.
    Quy Pham Nguyen
    Kanai, Masashi
    Kou, Tadayuki
    Kondo, Tomohiro
    Yamamoto, Yoshihiro
    Matsubara, Junichi
    Hiroshima, Akinori
    Mochizuki, Hiroaki
    Sakuma, Tomohiro
    Fukuyama, Keita
    Matsumoto, Shigemi
    Muto, Manabu
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [50] Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
    Zhu, Jiaxin
    Zhang, Tiantian
    Li, Jiahao
    Lin, Junming
    Liang, Wenhua
    Huang, Wenjie
    Wan, Ning
    Jiang, Jie
    FRONTIERS IN PHARMACOLOGY, 2019, 10
12345